CIO Influence
Apps CIO Influence News

Seqster Announces The Operating System for Patient Registries and Clinical Studies on Salesforce AppExchange, the World’s Leading Enterprise Cloud Marketplace

Seqster Announces The Operating System for Patient Registries and Clinical Studies on Salesforce AppExchange, the World's Leading Enterprise Cloud Marketplace
Salesforce customers can now benefit from Real World Data collection and patient engagement for all clinical studies

Seqster PDM, Inc. (“Seqster”) the leading patient-centric healthcare technology company, announced it has launched SeqsterOS, the Operating System for Patient Registries and clinical studies on Salesforce AppExchange, empowering life science enterprises to seamlessly integrate patient-consented Real World Data, including electronic health records (EHR), genomics, and device data, with a patient engagement layer for their clinical studies.

Top iTechnology Digital Trasformation News: Chronic Data Readiness Issues Impeding Digital Transformation in Healthcare

Integrated directly with Salesforce Health Cloud, SeqsterOS is currently available on AppExchange.

“SeqsterOS app is a welcome addition to AppExchange, as they power digital transformation for clients by empowering both clinical trials and patients on Salesforce Health Cloud,” said Woodson Martin, EVP & GM of Salesforce AppExchange. “AppExchange is constantly evolving to connect customers with the right apps and experts for their business needs.”

SeqsterOS automates real-time Real World Data (“RWD”) collection while improving the participant journey. Life science enterprises benefit from improved study participant engagement and retention. Study participants and researchers benefit from longitudinal health information essential for long-term observational studies and effectively conducting health economics & outcomes research (HEOR).

Top iTechnology IT And DevOps News: Asia Pacific’s IT, Business Services Market Up in Q1, But Growth Remains Uneven, ISG Index Finds

SeqsterOS on Health Cloud offers these additional benefits:

  • FDA 21 CFR Part 11 Compliance for drug submissions
  • De-identification and tokenization of data
  • E-Consent, eCOA
  • ePRO

“SeqsterOS empowers researchers with high-quality, high-fidelity health data directly from any source that can be readily utilized for analytics, AI, and RWE, accelerating the drug discovery cycle, all while improving the patient journey. By joining Salesforce AppExchange, we introduce our solution at scale for life science enterprise clients for application in clinical studies, whether in the traditional site-based setting or in decentralized trials,” said Ardy Arianpour, CEO & Co-Founder of Seqster.

Top iTechnology Cloud News: Inseego Appoints Chuck Becher as SVP and GM of Carrier Solutions

[To share your insights with us, please write to sghosh@martechseries.com]

Related posts

Quantiphi Achieves AWS Digital Customer Experience Competency Status

Elliptic Labs Shipping on Xiaomi Redmi K70e Smartphone

Business Wire

Docler Holding Selects DH2i’s DxEnterprise To Help Maintain Operations Uptime And Minimize Business Disruption Across Multinational Conglomerate

CIO Influence News Desk

Leave a Comment